Status:
WITHDRAWN
Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer
Lead Sponsor:
University of New Mexico
Conditions:
Cervical Cancer
Cervix
Eligibility:
FEMALE
Phase:
NA
Brief Summary
The Tissue Repository will search for cases, pull slides, Paraffin-embedded tissue (PET) blocks.
Detailed Description
This study is done to gather preliminary data for determining the best way to test EGFR expression in patients with cervical cancer who will receive treatment with EGFR inhibitors in the future. This...
Eligibility Criteria
Inclusion
- Samples from patients diagnosed with HG-SIL (n=300) and CC (n=300) with a follow-up of at least 24 months, existing at the Department of Pathology will be retrieved by the Tissue Repository, de-identified them and provided with code numbers that will not be linked to patient's data.
Exclusion
- None Specified.
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00298064
Start Date
December 1 2005
End Date
December 1 2005
Last Update
July 5 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of New Mexico
Albuquerque, New Mexico, United States, 87131